Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06064669

Effect of Metformin on Healthy Live Birth in Women With Prediabetes

Effect of Metformin on Healthy Live Birth After In-vitro Fertilization in Women With Prediabetes Mellitus: a Multicenter Double-blind Placebo Controlled Randomized Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
988 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

To evaluate the efficacy and safety of metformin pretreatment on reproductive outcomes in infertile women with prediabetes.

Detailed description

To evaluate the efficacy and safety of metformin pretreatment on reproductive outcomes in infertile women with prediabetes and to determine whether either starting metformin pretreatment before ovarian stimulation (aiming at improving the quality of oocyte/embryo) or starting before frozen embryo transfer (FET) (aiming at improving the receptivity of endometrium) could increase the chance of a healthy live birth compared with placebo.

Conditions

Interventions

TypeNameDescription
DRUGMetformin pretreatment before ovarian stimulationThe enrolled patients will be prescribed metformin 850mg twice daily for at least 4 weeks prior to ovarian stimulation till oocyte retrieval.
DRUGPlacebo pretreatment before ovarian stimulationThe enrolled patients will be prescribed placebo 850mg twice daily for at least 4 weeks prior to ovarian stimulation till oocyte retrieval.
DRUGMetformin pretreatment before endometrial preparation for frozen embryo transferAfter oocyte retrieval, the enrolled patients will be prescribed metformin 850mg twice daily for at least 4 weeks before endometrial preparation for frozen embryo transfer and till the establishment of clinical pregnancy (7-8 weeks gestation) after the first frozen embryo transfer.
DRUGPlacebo pretreatment before endometrial preparation for frozen embryo transferAfter oocyte retrieval, the enrolled patients will be prescribed placebo 850mg twice daily for at least 4 weeks before endometrial preparation for frozen embryo transfer and till the establishment of clinical pregnancy (7-8 weeks gestation) after the first frozen embryo transfer.

Timeline

Start date
2024-02-22
Primary completion
2026-12-31
Completion
2027-12-31
First posted
2023-10-03
Last updated
2024-05-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06064669. Inclusion in this directory is not an endorsement.